Why is the shortage in non-human primates such a serious issue for the scientific community?
Non-human primates (NHPs) are critical for clinical development pathways of new drug applications, but NHP suppliers are currently struggling to meet an unprecedented surge in global demand.
A National Institute of Health (NIH) survey of grants awarded between 2013 and 2017 revealed that nearly half of NIH-funded investigators reported difficulty in obtaining sufficient numbers of NHPs or related services for their research. The implications of this include critical delays in study initiation and widespread requests for grant extensions. These are driven by stretched timelines and increased costs, unforeseen when grant amounts were originally requested.+ Read more